Jonathan Symonds CBE was appointed as Deputy Group Chairman of HSBC Holdings plc in August 2018 and has been an independent non-executive Director since April 2014. He has extensive international financial and governance experience.

Mr Symonds was previously Chairman of HSBC Bank plc, HSBC’s European subsidiary, which offers services to clients in the UK and Continental Europe.

Mr Symonds was Chief Financial Officer of Novartis AG from 2009 to 2013. Before joining Novartis he was a Partner and Managing Director of Goldman Sachs; Chief Financial Officer of AstraZeneca plc; and a Partner at KPMG. His governance experience includes roles as non-executive Director and chair of the audit committees of Diageo plc and QinetiQ plc.

He is currently Chairman of Proteus Digital Health Inc. and of Genomics England Limited. He is also a non-executive director of Rubius Therapeutics, Inc.

Mr Symonds is a Fellow of the Institute of Chartered Accountants in England and Wales. He has a BA, First Class Honours in Business Finance from the University of Hertfordshire.

News and insight

A man with grey hair talks on a mobile phone

The demographic divide

Ageing populations may force governments to raise retirement ages, says HSBC’s James Pomeroy.

My sabbatical story

HSBC’s Andy Russell took six months off work to travel, thanks to the bank’s sabbatical policy.

Keeping the global engine running

Slowing growth and low inflation mean central banks face tough decisions, says HSBC’s Janet Henry.